AGENUS INC
For the period ended Dec 31, 2023. Filed Mar 14, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 14, 2024
AGEN$7.02-1.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
(Amounts in thousands, except per share amounts)
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Revenue: | |||
| Research and development | $38,764 | $16,975 | $244,422 |
| Service revenue | 2,978 | 10,514 | 6,704 |
| Royalty sales milestone | — | 25,250 | — |
| Other revenue | — | — | 184 |
| Non-cash revenue related to the sale of future royalties | 114,572 | 45,285 | 44,355 |
| Total revenues | 156,314 | 98,024 | 295,665 |
| Operating expenses: | |||
| Cost of service revenue | (3,111) | (10,568) | (3,470) |
| Research and development | (234,569) | (186,691) | (178,608) |
| General and administrative | (78,739) | (81,007) | (76,359) |
| Contingent purchase price consideration fair value adjustment | 556 | 815 | (11,481) |
| Operating income (loss) | (159,549) | (179,427) | 25,747 |
| Other income (expense): | |||
| Gain on extinguishment of debt | — | — | 6,197 |
| Loss on modification of debt | — | (1,937) | — |
| Non-operating income | 37 | 12,571 | 5,051 |
| Interest expense, net | (97,925) | (61,863) | (65,719) |
| Net loss | (257,437) | (230,656) | (28,724) |
| Dividends on Series A-1 convertible preferred stock | (213) | (212) | (211) |
| Less: net loss attributable to non-controlling interest | (11,676) | (10,582) | (4,798) |
| Net loss attributable to Agenus Inc. common stockholders | $(245,974) | $(220,286) | $(24,137) |
| Per common share data: | |||
| Basic and diluted net loss attributable to Agenus Inc. common stockholders | $(0.69) | $(0.78) | $(0.11) |
| Weighted average number of Agenus Inc. common shares outstanding: | |||
| Basic and diluted | 357,889 | 281,743 | 228,919 |
| Other comprehensive loss: | |||
| Foreign currency translation loss | $(1,870) | $(577) | $(1,280) |
| Other comprehensive loss | (1,870) | (577) | (1,280) |
| Comprehensive loss | $(247,844) | $(220,863) | $(25,417) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.